Exicure, Inc. (XCUR)
NASDAQ: XCUR · IEX Real-Time Price · USD
0.535
+0.231 (76.02%)
At close: Jul 19, 2024, 4:00 PM
0.399
-0.136 (-25.43%)
Pre-market: Jul 22, 2024, 9:13 AM EDT
Exicure Employees
Exicure had 6 employees as of December 31, 2023. The number of employees decreased by 7 or -53.85% compared to the previous year.
Employees
6
Change (1Y)
-7
Growth (1Y)
-53.85%
Revenue / Employee
$100,000
Profits / Employee
-$2,667,200
Market Cap
4.63M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Sharps Technology | 57 |
Intelligent Bio Solutions | 51 |
Predictive Oncology | 35 |
Theriva Biologics | 22 |
Processa Pharmaceuticals | 13 |
Adial Pharmaceuticals | 7 |
Portage Biotech | 7 |
Artelo Biosciences | 6 |
XCUR News
- 4 weeks ago - Exicure, Inc. Reports First Quarter 2024 Financial Results - Business Wire
- 6 weeks ago - Exicure, Inc. Reports Full Year 2023 Financial Results - Business Wire
- 2 months ago - Exicure, Inc. Received Nasdaq Notice of a Delisting Determination - Business Wire
- 2 months ago - Exicure, Inc. Reports Third Quarter 2023 Financial Results - Business Wire
- 3 months ago - Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-K - Business Wire
- 5 months ago - Exicure, Inc. and Bluejay Therapeutics Inc. Enter into a Patent License Agreement to Develop Cavrotolimod for the Treatment of Hepatitis - Business Wire
- 8 months ago - Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-Q - Business Wire
- 11 months ago - Exicure, Inc. Announces Appointment of New CEO and CFO and Changes to Board of Directors - Business Wire